RESMED INC — Director's Dealing 2023

Jan 18, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2023-01-17

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-17	ResMed Common Stock	M	5675	$57.76	Acquired	442575	Direct
2023-01-17	ResMed Common Stock	S	5675	$224.3645	Disposed	436900	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-17	ResMed Common Stock Options	$57.76	M	5675	Disposed	2023-11-16	ResMed Common Stock (5675)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	4090	Indirect

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: This transaction was executed in multiple trades at prices ranging from $220.59 - $225.635. The price reported above reflects the weighted average sale price.

F3: Represents date options first became exercisable. Options vest 1/3 per year.